Lagumbay, Althea T.

HRN: 28-51-10  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2026
AMPICILLIN 250MG (VIAL)
01/31/2026
02/04/2026
IV
70 Mg
Q 12
Prematurity
Remove - Pending Acceptance
01/31/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
01/31/2026
02/04/2026
IV
7mg
Q 36 Hours
Prematurity
Remove - Pending Acceptance
02/04/2026
CEFTAZIDIME 1GM (VIAL)
02/04/2026
02/21/2026
IV
70mg
Q12h
T/C Neonatal Sepsis
Remove - Pending Acceptance
02/05/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/05/2026
02/11/2026
IV
21mg
OD
T/C Neonatal Sepsis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: